Navigation Links
MedCath Announces Completion of Sale of Dayton Heart Hospital to Good Samaritan Hospital-Dayton
Date:5/19/2008

CHARLOTTE, N.C., May 19 /PRNewswire-FirstCall/ -- MedCath Corporation (Nasdaq: MDTH), its physician partners and Good Samaritan Hospital, Dayton, Ohio, jointly announced today that the parties have completed the sale of Dayton Heart Hospital to Good Samaritan Hospital. Under terms of the transaction, Good Samaritan purchased substantially all of Dayton Heart Hospital's assets for $55.0 million.

Net proceeds to MedCath, after income tax expense related to the gain on sale and liquidation of net working capital retained by the hospital partnership, are anticipated to total approximately $32.0 million. MedCath will use the proceeds for general corporate purposes, including investment in other hospital projects.

Opened in 1999, Dayton Heart Hospital is a 47-bed hospital focused on providing cardiovascular care to the Dayton community. A member of the Premier Health Partners system, Good Samaritan Hospital (Dayton, Ohio) is a 577-bed, full-service teaching facility with a 75-year history that delivers best-in-care cardiovascular, cancer and orthopedics services. Recently, the Joint Commission awarded gold seal certifications to the Good Samaritan's outstanding heart failure, heart attack, breast cancer and artery bypass graft surgery programs. Additionally, HealthGrades, the leading independent quality monitoring organization in the country, named Good Samaritan as a recipient of its 2008 Distinguished Hospital Award for Clinical Excellence, which places it among the top 5 percent of hospitals nationwide.

"We've enjoyed our longstanding relationship with our physician partners in working jointly to provide quality cardiovascular care to the residents in Dayton and nearby communities," said O. Edwin French, MedCath's President and Chief Executive Officer. "We wish them and Good Samaritan continued success in servicing the healthcare needs of the local market."

MedCath Corporation, headquartered in Charlotte, N.C., is a healthcare provider focused on high acuity services with the diagnosis and treatment of cardiovascular disease being a primary service offering. MedCath owns an interest in and operates nine hospitals with a total of 616 licensed beds, located in Arizona, Arkansas, California, Louisiana, New Mexico, South Dakota, and Texas. MedCath is in the process of developing its tenth hospital in Kingman, Arizona. In addition, MedCath and its subsidiary MedCath Partners provide services in diagnostic and therapeutic facilities in various states.

Parts of this announcement contain forward-looking statements that involve risks and uncertainties. Although management believes that these forward- looking statements are based on reasonable assumptions, these assumptions are inherently subject to significant economic, regulatory and competitive uncertainties and contingencies that are difficult or impossible to predict accurately and are beyond our control. Actual results could differ materially from those projected in these forward-looking statements. We do not assume any obligation to update these statements in a news release or otherwise should material facts or circumstances change in ways that would affect their accuracy.

These various risks and uncertainties are described in detail in "Risk Factors" in MedCath's Form 10-K filed with the Securities and Exchange Commission on December 14, 2007, a copy of which is available on the internet site of the Securities and Exchange Commission at http://www.sec.gov.


'/>"/>
SOURCE MedCath Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. MedCath Names Parker to New Finance Post
2. MedCath Corporation to Present at the Banc of America Securities 2008 Health Care Conference
3. MedCath Corporation Reports Second Quarter Earnings
4. MedCath Corporation to Present at the Deutsche Bank Securities 33rd Annual Health Care Conference
5. MedCath Provides Preliminary Second Quarter Fiscal 2008 Earnings and Updates Fiscal 2008 Outlook
6. Woodrin Woody Grossman Appointed to MedCaths Board of Directors
7. Pamela G. Bailey and Edward R. Casas, M.D. Appointed to MedCaths Board of Directors
8. MedCath Announces Acquisition of Ownership in Arizona Cath Lab
9. MedCath Enters Definitive Agreement to Sell Dayton Heart Hospital to Good Samaritan Hospital-Dayton
10. MedCath Corporation to Present at the Citi 2008 Small and Mid-Cap Conference
11. MedCath Corporation to Present at the Raymond James 29th Annual Institutional Investors Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/18/2017)... ... August 18, 2017 , ... ... financial consultations to communities throughout the greater DC region, is inaugurating a “New ... of rescuing local animals and training them to be companions for veterans in ...
(Date:8/18/2017)... Plantation, FL (PRWEB) , ... August 18, 2017 ... ... asset protection and financial planning assistance that serves communities throughout southern Florida, is ... event to provide scholarship assets to children from low income families. , The ...
(Date:8/18/2017)... ... August 18, 2017 , ... The Golseth Agency, a Texas based insurance ... is spearheading a regional charity campaign organized to provide support to Christina Upchurch and ... this year, Christina and her children returned from out of town to find her ...
(Date:8/18/2017)... Abilene, Texas (PRWEB) , ... August 18, 2017 , ... Yisrayl Hawkins, Pastor and Overseer ... that he says will lift the veil on false teachings pertaining to the mother of ... Holy Scriptures teach, you see a far different picture of the role of this historical ...
(Date:8/18/2017)... (PRWEB) , ... August 18, 2017 , ... ... numbers and call tracking and monitoring solutions, announced today the launch of a ... include a modern navigation and aesthetic, fully responsive design, and an enhanced search ...
Breaking Medicine News(10 mins):
(Date:8/7/2017)... Mich., Aug. 7, 2017  Diplomat Pharmacy, Inc. (NYSE: DPLO), ... the quarter ended June 30, 2017.  All comparisons, unless otherwise ... Second Quarter 2017 Highlights ... to $1,089 million, an increase of 3.5% ... Gross margin of 7.5% versus 7.6% ...
(Date:8/4/2017)... 3, 2017  Agragen, LLC, a ... the biopharmaceutical, nutraceutical, and aquacultural feed sectors, announces ... lead drug candidates, AGR131.  This drug is designed ... the blood of patients suffering from inflammatory conditions ... disease. Biological ...
(Date:8/2/2017)... MEMPHIS, Tenn. and BENTON, Ky. , Aug. 2, 2017 /PRNewswire/ ... new member to its environmental services (ES) team to proactively reduce the risk of hospital-acquired ... is a UV disinfection robot that uses UVC light energy to kill deadly pathogens such ... ... Tru-D ...
Breaking Medicine Technology: